Bacteremic infections in granulopenic patients in Israel

Related Experiment Videos

Y Siegman-Igra1, D Schwartz, I Gonen

  • 1Infectious Disease Unit, Rokach (Hadassah) Hospital, Tel Aviv, Israel.

Israel Journal of Medical Sciences
|December 1, 1987
PubMed

Insights

This study reviewed 44 bacteremic, granulopenic patients, finding Pseudomonas aeruginosa most common. Hospital-acquired infections, often urinary tract related, showed increased antimicrobial resistance.

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Hospital Epidemiology

Background:

  • Bacteremia and granulopenia in hospitalized patients present significant clinical challenges.
  • Understanding causative organisms and infection patterns is crucial for effective treatment.
  • Previous data on antimicrobial resistance in these patient groups requires updated insights.

Purpose of the Study:

  • To analyze the spectrum of microorganisms causing bacteremia in granulopenic patients.
  • To identify the common sources and types of infections in this vulnerable population.
  • To assess antimicrobial resistance patterns, particularly in hospital-acquired infections.

Main Methods:

  • Retrospective review of 44 bacteremic, granulopenic patients over a 4-year period (1980-1983).
  • Identification and characterization of 54 recovered bacterial organisms.
  • Analysis of infection acquisition (hospital-acquired vs. community-acquired) and primary focus.

Main Results:

  • Gram-negative bacteria predominated (83%), with Pseudomonas aeruginosa being the most frequent isolate.
  • Hospital-acquired infections accounted for 70% of cases, with the urinary tract as the most common site.
  • Increased antimicrobial resistance was observed in hospital-acquired infections and in patients already on antimicrobials.

Conclusions:

  • Pseudomonas aeruginosa is a key pathogen in bacteremic granulopenic patients.
  • Urinary tract infections are a common focus, especially in hospital-acquired settings.
  • Antimicrobial resistance is a growing concern, particularly in healthcare-associated infections and among patients receiving prior antimicrobial therapy.

Related Concept Videos